Head-to-head · WeighScore
Longevixx vs Mevo Health
The verdict
Longevixx takes it — 70.7/100 to 60.2/100.
Longevixx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Longevixx sells lab-informed dosing and cadenced check-ins, publishes no lab price and no lab requirement, and prints “same price, no hidden fees” above a card that rises after month one.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Longevixx | Mevo Health |
|---|---|---|
| WeighScore | 70.7/100 | 60.2/100 |
| Grade | C | C |
| Site position | #113 | #371 |
| Semaglutide | $199/mo (standing rate; $149 covers the first month only) | $199/mo (all doses, compounded) |
| Tirzepatide | $299/mo (standing rate) | $259/mo (all doses, compounded) |
| Coverage | All 50 states (claimed; the contact page says licensed states only) | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #113 · C
Strengths
- A large priced peptide program list sits beside the GLP-1 lines, so most of the menu carries figures
- Care coaching, a dietitian visit and physician review are listed as included in every plan at no separate charge
- Free expedited shipping is quoted with a stated two- to three-day window rather than left vague
- A same-day clinician call is offered at no extra charge if one is needed
- Publishes clinical hours of Monday to Friday, 9:00 AM to 5:00 PM
Where it loses points
- $149 is the first-month semaglutide price and the standing rate is $199, while the homepage floor still reads “from $149/mo”
- “Same price, all dosages, no hidden fees, everything included” sits directly above a card whose price rises after month one
- The site markets structured lab work and lab-informed dosing, publishes no lab price, states no lab requirement, and the intake never asked for labs
- Patient counts and average ratings are published at three different values across the homepage and the funnel, with no review platform named for any of them
- Checkout claims 24/7 access to the care team against published clinical hours of Monday to Friday, 9 to 5
- No compounding pharmacy, medical group, clinician or NPI is published anywhere
- There is no refund policy page and no general refund right
Site position #371 · C
Strengths
- LegitScript verification badge on multiple pages
- Publishes the FDA compounded-medication disclaimer
- Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
- Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
- Public entry-level pricing surfaced
Where it loses points
- States served not listed on any public page
- Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
- No formal Medical Director role disclosed
- Only 'as low as' entry pricing shown — no per-dose itemization
- No SOC 2 certification claimed
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.